Los Angeles, CALIFORNIA1 Active Studies

Fabry Disease Clinical Trials in Los Angeles, CALIFORNIA

Find 1 actively recruiting fabry disease clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
18
Enrolling

Recruiting Fabry Disease Studies in Los Angeles

About Fabry Disease Clinical Trials in Los Angeles

Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.

There are currently 1 fabry disease clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 18 participants. Research is being sponsored by GC Biopharma Corp. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fabry Disease Clinical Trials in Los Angeles — FAQ

Are there fabry disease clinical trials in Los Angeles?

Yes, there are 1 fabry disease clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What fabry disease treatments are being tested?

The 1 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.

Data updated March 2, 2026 from ClinicalTrials.gov